![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA APPROVES TAKEDA'S ACTOPLUS MET DIABETES DRUG
FDA APPROVES TAKEDA'S ACTOPLUS MET DIABETES DRUG
August 30, 2005
The FDA has approved Takeda Pharmaceutical's Actoplus Met, a drug for Type 2 diabetes. Takeda, Japan's largest drugmaker, will start selling the drug in the U.S. in October. Actoplus Met combines in a single tablet Takeda's widely used Actos diabetes treatment and another diabetes therapy called metformin.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
21Oct